Sign inJoin waitlistJoin the waitlist

Jubilee Brown

Division Director · Carolinas Medical Center

Credentials: · · · · ·

History

Wake Forest University Baptist Medical Center
Present

Gynecologic Oncology
University of Texas M D Anderson Cancer Center
2001–2004
Obstetrics and Gynecology
University of Maryland School of Medicine
1997–2001
University of Cincinnati College of Medicine
1989–1993

Research

Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor…
Cancer Research · 2000 · 328 citations
Clinical Activity and Safety of the Anti-Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer: A…
JAMA Oncology · 2020 · 286 citations
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable…
Journal for ImmunoTherapy of Cancer · 2022 · 271 citations

Wendel Naumann
26 papers
David Gershenson
21 papers
Lois Ramondetta
21 papers
Erin Crane
17 papers · 5 as a resident
Michael Frumovitz
13 papers · 1 as a fellow
DT
David Tait
12 papers
Pedro Ramirez
11 papers
RC
Robert Coleman
11 papers
JW
Judith Wolf
10 papers
Kathleen Schmeler
10 papers · 1 as a fellow
Brian Slomovitz
8 papers · 2 as a fellow
ML
Mario Leitao
8 papers

Clinical trials

Open-label Study to Evaluate Nerindocianine as a Surgical Aid in Ureter Delineation During Minimally Invasive Surgery
Principal investigator · Withdrawn · Phase 2
Li-Cor, Inc.
2021
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Principal investigator · Unknown · Phase 2
GOG Foundation
2010–2022
Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2008–2013
Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2004–2013